The store will not work correctly when cookies are disabled.
1-(3,4-difluorophenyl)-3-(3-methyl-1-(pyridin-4-yl)-1H-pyrazol-5-yl)urea
ID: ALA2409111
Chembl Id: CHEMBL2409111
PubChem CID: 71812408
Max Phase: Preclinical
Molecular Formula: C16H13F2N5O
Molecular Weight: 329.31
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(NC(=O)Nc2ccc(F)c(F)c2)n(-c2ccncc2)n1
Standard InChI: InChI=1S/C16H13F2N5O/c1-10-8-15(23(22-10)12-4-6-19-7-5-12)21-16(24)20-11-2-3-13(17)14(18)9-11/h2-9H,1H3,(H2,20,21,24)
Standard InChI Key: JKIMRYPNCLSUKU-UHFFFAOYSA-N
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 329.31 | Molecular Weight (Monoisotopic): 329.1088 | AlogP: 3.50 | #Rotatable Bonds: 3 |
Polar Surface Area: 71.84 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.31 | CX Basic pKa: 6.93 | CX LogP: 2.49 | CX LogD: 2.38 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.77 | Np Likeness Score: -2.77 |
References
1. Wen W, Wu W, Romaine IM, Kaufmann K, Du Y, Sulikowski GA, Weaver CD, Lindsley CW.. (2013) Discovery of 'molecular switches' within a GIRK activator scaffold that afford selective GIRK inhibitors., 23 (16): [PMID:23838260] [10.1016/j.bmcl.2013.06.023] |